PBS item and GP route
Eight health systems, eight practical routes
How naltrexone access changes by country
Start with the exact formulation you are looking for. A country may fund a 50 mg tablet, list only a naltrexone-bupropion product, or use a specialist pathway even when the medicine itself is well established.
A prescription has several moving parts
Finding a regulator entry is only the first step. The exact product may still need a particular prescriber, approval code, pharmacy order, insurer check, or out-of-pocket payment.
The table below is a dated orientation, not a promise of stock or personal eligibility. Use the country page for source links and the questions to take to a clinician, pharmacy, or payer.
Access snapshot checked 26 July 2026 (scroll horizontally on smaller screens)
| USA | UK | Canada | Australia | NZ | Singapore | South Africa | UAE | |
|---|---|---|---|---|---|---|---|---|
| Standalone oral product | Multiple US generic labels | 50 mg tablet pathway in NICE guidance | Authorised oral generics; coverage varies | PBS item 8370M | Naltraccord 50 mg | No currently marketed product verified in this review | Naltima 50 mg price record | Not found in the live EDE search |
| Naltrexone/bupropion product | Contrave | Mysimba | Contrave | Contrave | Check the current register | Contrave SIN16411P | Contrave | Contrave active entry |
| Public funding or price clue | Plan-specific | Drug Tariff pack price; patient charge varies | Province and plan-specific | PBS maximum co-payment | Funded under SA1408; other fees may apply | No reliable standalone public price found | Naltima Single Exit Price | No reliable standalone public price found |
| Useful next check | Coverage and prior authorisation | Local NHS initiation route | Provincial criteria and pharmacy stock | PBS eligibility and prescriber | SA1408 eligibility and service fees | Exact product, special supply, and quote | Dispensing fee and stock | Special-supply route for standalone treatment |
Choose the guide that matches where care is delivered
Each page keeps the official record beside the practical next step.
Provincial coverage checks
Canada
Naltraccord and SA1408
New Zealand
Contrave confirmed; standalone uncertain
Singapore
Naltima and Contrave records
South Africa
Registry and special-supply questions
United Arab Emirates
NICE and NHS route
United Kingdom
Oral, injection, and insurance
United States
Ask four separate questions
This prevents a yes/no answer from hiding the part that affects you.
Which product?
Oral naltrexone, Vivitrol, and Contrave have different purposes and access routes.
Who starts it?
A GP may prescribe in one system while a specialist service initiates treatment in another.
Who pays?
A register, tariff, subsidy, insurer formulary, and final pharmacy bill are different records.
Who has it today?
Only the current supplying service or pharmacy can confirm local stock and timing.
Prepare one precise local question
Name the formulation, treatment purpose, country, and payment route. That will get a more useful answer than asking only whether ‘naltrexone is available’.
Sources
This table is a dated synthesis. Each country guide gives the surrounding context and source notes.
Content and sources reviewed